Derivative Financial Instruments (Tables)

3 Months Ended

Apr. 01, 2012

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule Of Fair Values Of The Company's Derivative Instruments And The Line Items On The Consolidated Balance Sheets

The fair values of the Company’s derivative instruments and the line items on the Unaudited Condensed Consolidated Balance Sheet to which they were recorded as of April 1, 2012, and December 31, 2011, are summarized as follows (in thousands):

Derivative Assets	Balance Sheet Location	Fair Value at April 1, 2012		Balance Sheet Location	Fair Value at December 31, 2011
Derivative assets not designated as hedging instruments	Prepaid expenses and other current assets	$	361	Prepaid expenses and other current assets	$	1,196
Derivative assets designated as hedging instruments	Prepaid expenses and other current assets	—		Prepaid expenses and other current assets	41
Total		$	361		$	1,237

Derivative Liabilities	Balance Sheet Location	Fair Value at April 1, 2012			Balance Sheet Location	Fair Value at December 31, 2011
Derivative liabilities not designated as hedging instruments	Other accrued liabilities	$	(304	)	Other accrued liabilities	$	(654	)
Derivative liabilities designated as hedging instruments	Other accrued liabilities	(44		)	Other accrued liabilities	(69		)
Total		$	(348	)		$	(723	)

Schedule Of Company's Derivative Instruments On Other Comprehensive Income And The Consolidated Statement Of Operations

The effects of the Company’s derivative instruments on OCI and the unaudited condensed consolidated statement of operations for the three months ended April 1, 2012, and April 3, 2011, are summarized as follows (in thousands):

Derivatives Designated as Hedging Instruments	Three Months Ended April 1, 2012
	Gain or (Loss) Recognized in OCI - Effective Portion (a)			Location of Gain or (Loss) Reclassified from OCI into Income - Effective Portion	Gain or (Loss) Reclassified from OCI into Income - Effective Portion (a)			Location of Gain or (Loss) Recognized in Income and Excluded from Effectiveness  Testing	Amount of Gain or (Loss) Recognized in Income and Excluded from Effectiveness  Testing
Cash flow hedges:
Foreign currency forward contracts	$	(106	)	Net revenue	$	2		Other income (expense), net	$	(45	)
Foreign currency forward contracts	—			Cost of revenue	(2		)	Other income (expense), net	—
Foreign currency forward contracts	—			Operating expenses	(50		)	Other income (expense), net	—
Total	$	(106	)		$	(50	)		$	(45	)

Derivatives Designated as Hedging Instruments	Three Months Ended April 3, 2011
	Gain or (Loss) Recognized in OCI - Effective Portion (a)			Location of Gain or (Loss) Reclassified from OCI into Income - Effective Portion	Gain or (Loss) Reclassified from OCI into Income - Effective Portion (a)		Location of Gain or (Loss) Recognized in Income and Excluded from Effectiveness  Testing	Amount of Gain  or (Loss)  Recognized in Income and Excluded from Effectiveness  Testing
Cash flow hedges:
Foreign currency forward contracts	$	(218	)	Net revenue	$	62	Other income (expense), net	$	(38	)
Foreign currency forward contracts	—			Cost of revenue	2		Other income (expense), net	—
Foreign currency forward contracts	—			Operating expenses	59		Other income (expense), net	—
Total	$	(218	)		$	123		$	(38	)

(a) Refer to Note 10, Stockholders' Equity, which summarizes the activity in other comprehensive income related to derivatives.

Schedule Of Derivatives Not Designated As Hedging Instruments

The effects of the Company’s derivatives not designated as hedging instruments in other income (expense), net on the Statement of Operations for the three months ended April 1, 2012 and April 3, 2011, are as follows (in thousands):

Derivatives Not Designated as Hedging Instruments	Location of Gains or (Losses) Recognized in Income on  Derivative	Amount of Gains or (Losses) Recognized in Income on Derivative
		Three Months  Ended April 1, 2012			Three Months  Ended April 3, 2011
Foreign currency forward contracts	Other income (expense), net	$	(744	)	$	(1,858	)